Doxazosin 13C4
| Product Name | Doxazosin 13C4 |
|---|---|
| Alternate Names | Doxazosin Stable Isotopes, Stable Isotopes of Doxazosin |
| CAT No. | CS-EK-02567 |
| CAS No. | 74191-85-8 unlabeled |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Doxazosin |
| Canonical Smiles | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC |
| InchIKey | RUZYUOTYCVRMRZ-UHFFFAOYSA-N |
| Inchl | InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26) |
| IUPAC | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
[13C4]-Doxazosin is a labeled version of the drug doxazosin, where four of the carbon atoms have been replaced with the stable isotope carbon-13. This labeled compound is primarily used in pharmacokinetic studies to track the metabolism and distribution of doxazosin in the body.
Doxazosin is a medication that belongs to the class of alpha-1 blockers, which work by relaxing the smooth muscles in the prostate gland and bladder neck, making it easier for urine to flow. This medication is commonly prescribed to treat hypertension (high blood pressure) and benign prostatic hyperplasia (enlarged prostate gland).
The labeled version of doxazosin, [13C4]-Doxazosin, is used in clinical studies to determine the pharmacokinetics of the drug. This involves tracking the absorption, distribution, metabolism, and elimination of the drug in the body. The labeled drug can be tracked using mass spectrometry and other analytical techniques to determine the concentration of the drug in blood, urine, and other bodily fluids.
The labeling of [13C4]-Doxazosin allows for more accurate and precise measurements of the drug in the body, which can lead to better dosing recommendations and treatment outcomes. Additionally, the use of labeled drugs in clinical studies can provide valuable insights into drug metabolism, drug-drug interactions, and potential adverse effects.
Get an Instant Quote
Related Compounds
S-Doxazosin D8 | Doxazosin-d8 Hydrochloride | R-Doxazosin 13C4 | Doxazosin D8 | R-Doxazosin D8 |